Who We Are

Lysine Biotech is a Made in Tamilnadu-India based start-up biotech company established in the year 2018.

We are currently involved in developing therapeutics against diabetics and acutely decompensated congestive heart failure with dyspnea at rest. Our aim is to provide affordable, safe and effective drugs/vaccine for diseases with global prevalence. We have i) Development of 1st fourteen-in-One, 2nd fourteen-in-One and 3rd fifteen-in-One GeneX viral-based Recombinant unique peptide vaccine and RNA-Targeted small unique antipeptide viral molecule Drug for Treatment and Prevention of PANCOVID and ii) PROTAC has gained tremendous momentum for its promise to discover and develop new drugs in pipeline.

Lysine Biotech is committed to product development and manufacturing of drugs, biomarker and vaccines for several disease, Infectious diseases and biological molecules are produced from living organisms and range from DNA and protein through in-silico and wet lab technologies, which are useful for the medicinal and industrial applications.

Learn More About Us

Our Features

Long non coding reading frames endless RNA (lncrfeRNA)

long non coding reading frames endless RNA (lncrfeRNA)1,— a new class of programmable medicines capable of expressing therapeutic proteins, Membrane Proteins, Peptides, Antibodies, Vaccine inside the body.

i) lncrfeRNA engineered to translate programmed frame genetic non code and express proteins
ii)Stability functions and long lasting.
iii)long non-coding reading frames regions to used for various tasks, including post-transcriptional regulation, organization of protein complexes, control expression, stability, targeting, cell-cell signalling, allosteric regulation of proteins and more.

Reference

1.P. Anandagopu et.al.Role of Thymine in Protein Coding Frames of mRNA Sequences. Bioinformation. 2008. 2, 304-307.

Learn More About Technology